Brian K. Halak, 10% Owner at Orexigen Therapeutics, Inc. (OREX), bought 413,000 shares at $8.00 ($3.3M) on 2009-08-12, disclosed to the SEC on 2009-08-14.
Open-market purchase of $3.3M OREX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.00 | 6,708 | $54K | 1.6% |
| 2 | $8.00 | 393,292 | $3.1M | 95.3% |
| 3 | $7.85 | 218 | $2K | 0.1% |
| 4 | $7.85 | 12,782 | $100K | 3.0% |
| Total | $8.00 avg | 413,000 | $3.3M | 100% |
| Filing → |
| DRNA | SELL | 2018-11-01 | $2.5M | — | Filing → |
| EVOK | SELL | 2015-08-20 | $1K | — | Filing → |
| ATRA | BUY | 2014-10-21 | $20K | — | Filing → |